Unwarranted Fear About The Effects Of Radiation Leads To Bad Science Policy

Few issues have caused more fear and confusion than the question of the hazards of low-level radiation. There has been a remarkable failure to examine closely the evidence when discussing the issue and planning future studies. As a result, the public’s radiation phobia has been needlessly reinforced, and public money is being used on studies that are bound to be inconclusive. The problem arises, in part, because the general public—and even most scientists—are not aware that

| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

The problem arises, in part, because the general public—and even most scientists—are not aware that exposure to ionizing radiation is only weakly carcinogenic. The evidence comes from a number of different studies. Among the 82,000 survivors of the Hiroshima-Nagasaki bombing, for example, an average exposure of 27 rem only raised the number of cancer deaths by 6% over the number expected in the absence of such exposure. Radiation-induced leukemia among the survivors began to appear two to three years after exposure, reached a peak at five to six years, and declined thereafter.

Studies in experimental animals have shown that the duration of the exposure, not just overall dose, is important. Acute exposure generally results in a much higher incidence of tumors than does the same dose delivered over a period of hours to days. It is possible that the Chernobyl accident may provide a direct answer about dose-rate effects in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Rosalyn Yalow

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours